Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the following distinguished Key Opinion Leaders will be...

Related Keywords

Canada ,United States ,Japan ,Belgium ,New York ,United Kingdom ,Melbourne ,Victoria ,Australia ,Switzerland ,Australian ,American ,Alvin Carrie Meinhardt ,Lisa Wilson ,Christian Behrenbruch ,Scottt Tagawa ,Scott Tagawa ,Brian Shuch ,Colin Hayward ,Kyahn Williamson ,Kevin Richardson ,Linkedin ,Prnewswire Telix Pharmaceuticals Limited ,Site Communications ,Australian Therapeutic Goods Administration ,Yale Club ,Kidney Cancer Research ,Kidney Cancer Association ,Drug Administration ,European Union ,Clinical Cancer Research ,Australian Securities Exchange ,Corporate Communications ,American Society Of Clinical Oncology ,Health Canada ,Telix Pharmaceuticals ,Kidney Cancer Program ,National Cancer Institute ,Renal Task ,Key Opinion Leaders ,Pharmaceuticals Limited ,New York City ,Cancer Program ,Carrie Meinhardt Endowed Chair ,Kidney Cancer ,Urologic Oncology Fellowship ,National Cancer ,Task Force ,Nature Genetics ,Clinical Cancer ,New York Based Professor ,American Society ,Clinical Oncology ,Telix Pharmaceuticals Limited ,